Candela Corp - Company Profile
Powered by 
All the data and insights you need on Candela Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Candela Corp Strategy Report
- Understand Candela Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Candela Corp (Candela), a subsidiary of Apax Partners LLP, is a non-surgical aesthetic medical device company. It designs, develops, and markets aesthetic medical products. The company’s products target a range of non-invasive aesthetic medical procedures and address a range of cosmetic and medical indications such as treatment of leg veins, acne treatment, wrinkle reduction, hair removal, skin rejuvenation of the skin’s appearance, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and a minimally invasive product for laser-assisted lipolysis. Candela employs its proprietary Electro-Optical Synergy (ELOS) technology to develop aesthetic medical products. It sells products through a network of distributors and has offices in North America, France, the UK, Italy, Portugal, Germany, Spain, China, Japan, Australia, and Hong Kong. Candela is headquartered in Marlborough, Massachusetts, the US.
Headquarters
United States of America
Address
251 Locke Drive, Marlborough, Massachusetts, 01752
Website
candelamedical.com
Telephone
1 508 3587400
Industry
Medical Equipment
Candela Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | SYNERON |
| Hair Removal | ELOS |
| eLase with Motif | COOLTOUCH |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Product Approvals | In June, the company receives a FDA clearance of Vbeam 595 nm pulsed dye laser, a gold standard for vascular treatment and port wine stains and hemangiomas in the pediatric population. |
| 2022 | Others | In July, the company agreed to be sold by Apax Partners for US$1 billion. |
| 2020 | New Product Approvals | In May, the company received FDA approval for its Gentlemax Pro Plus, intended for the treatment of benign pigmented lesions and wrinkles. |
Competitor Comparison
| Key Parameters | Candela Corp | Alma Lasers Ltd | Cynosure Inc | Lumenis Be Ltd | Lutronic Aesthetics Inc (Inactive) |
|---|---|---|---|---|---|
| Headquarters | United States of America | Israel | United States of America | Israel | United States of America |
| City | Marlborough | Caesarea | Westford | Yokneam | Princeton Junction |
| State/Province | Massachusetts | Haifa | Massachusetts | - | New Jersey |
| No. of Employees | - | - | 982 | - | - |
| Entity Type | Private | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Geoffrey Crouse | Chief Executive Officer | Senior Management | 2017 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer